Genmab — Februar 2025

[lahn1]

So I think in the industry, 3 years from now, it's going to be 1 of the top 3 biggest cancer drugs on earth. Right now it's the biggest product for JNJ and then to have a better one, which is differentiated. I think it's potentially super exciting.”

[JKY_VH]

lahn1, det understreger vel at hvis ikke JNJ/Genmab udvikler et bedre præparat end Dara, så gør andre det kannibalisering eller ej.

[exitnu]

Genmab (GMAB) Gets a Hold from Morgan Stanley, price target of $31.00 (Feb. 18, 2025, 07:16 AM).

[E_L]

whatever happens, one would expect HexaCD38 to be marketed in combination anyway, no? and if that combo is with Tec or Tal; all the better

[lahn1]

yes Jan eluted to that point. Treatment is al about combination.

[lahn1]

Ja enten disrupter du dig selv eller også disrupter andre dig, period !

[Sukkeralf]

Yes but if Genmab is doing th clinical trials they probably need to buy tec and tal - so its so much easier if Janssen takes the option

[E_L]

it is definitely easier; i think we established that long time ago. And best for the short term share price reaction. And my blood pressure... (whether JNJ would or would not sponsor the Tec or Tal , is really a
minor issue i would think)

[E_L]

New trial - eal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma / EpcoReal: A Multi-country, Prospective Observational Study of Epcoritamab in NHL Comprising Two Patient Cohorts (3L+ (D)LBCL and 3L+ FL) https://clinicaltrials.gov/study/NCT06830759

[gentogen]

Daratumumab is increasingly used in first-line, and soon patients that relapse while on daratumumab will become a common challenge.

[gentogen]

ScienceDirect

(www.sciencedirect.com)

[ProinvestorNEWS]

Teknisk: Genmab i brud op gennem vigtige modstande, fortsætter op i USA https://proinvestor.com/investornyt/1279889/teknisk-genmab-i-brud-op-gennem-vigtige-modstande-fortsaetter-op-i-usa

[E_L]

Leo Habets
@L_Habets
Daratumumab Seit einiger Zeit behandeln wir Post, COVID, Post Vac und MEC FS Patienten mit Daratumumab wir haben jetzt insgesamt sieben Patienten in der Behandlung https://x.com/L_Habets/status/1891069465686634514 https://x.com/L_Habets/status/1891210734530400443

[bikube]

die Behandlung ist teuer, die kostet 20000€ fyr 4 gaben. Det er vist første gang, jeg har set en kontant pris på Dara.

[E_L]

TipRanks
Feb. 19, 2025, 01:35 AM
In a report released today, Emily Field from Barclays maintained a Buy rating on Genmab A/S
, with a price target of DKK2,100.00.

[E_L]

looks like we will get an Acasunlimab Poster at the European Lung Cancer Congress at the end of the March https://cslide.ctimeetingtech.com/coasis_21204/attendee/confcal/presentation/list?q=acasunlimab Also a few for amivantamab, also orals

[E_L]

Kempen erhöht Kursziel für Genmab auf DKK 3.070 (2.950) und bekräftigt Kaufen - BN
Am 19. Februar 2025 https://de.marketscreener.com/kurs/aktie/GENMAB-A-S-63733191/news/Kempen-erhoht-Kursziel-fur-Genmab-auf-DKK-3-070-2-950-und-bekraftigt-Kaufen-BN-49100440/

[Bulder]

Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano and Chief Development Officer Judith Klimovsky will participate in a fireside chat at the 45th Annual TD Cowen Health Care Conference, nå Winkel skal ikke med.

[ProinvestorNEWS]

Hvordan ser fremtiden ud for forsvarsaktierne i en tid med mulige milliardinvesteringer i mange lande? Hør også om Genmabs kommende og vigtige afgørelse, kollapset i Bavarian Nordic samt meget andet i afsnit 262 af Investeringspodcasten. https://proinvestor.com/boards/124824

[royal]

Er lidt forvirret: 60 dage fra ca. 1. januar = Ultimo februar. 1. kvartal 2025 som Jan selv siger?